Back to Browse Journals » Biologics: Targets and Therapy » Volume 2 » Issue 4

The insulin-like growth factor system and its receptors: A potential novel anticancer target

Authors Colin R. Lindsay, T R Jeffry Evans

Published Date September 2008 Volume 2008:2(4) Pages 855—864

DOI http://dx.doi.org/10.2147/BTT.S3841

Published 18 September 2008

Colin R. Lindsay1, T R Jeffry Evans1,2

1Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; 2University of Glasgow, CR-UK Beatson Laboratories, Garscube Estate, Glasgow, United Kingdom

Abstract: The current generation of novel anticancer therapies that are in preclinical and clinical development are based on exploiting our increasing understanding of the molecular and cellular basis of cancer development and progression. Accelerated rates of cell division and proliferation have been postulated to predispose to the development of malignant disease. The insulin-like growth factor (IGF) signaling system has an important physiological role in regulating cellular proliferation and apoptosis. This function has led to considerable interest in its relevance to neoplasia over the last decade. In this review, we give an overview of the IGF system physiology, discuss the epidemiological significance of IGF signaling and neoplasia, and review the preclinical and clinical studies in targeting IGF receptors as cancer therapies.

Keywords: insulin, growth factor, IGF-1, clinical trials

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

A novel biclustering approach with iterative optimization to analyze gene expression data

Sutheeworapong S, Ota M, Ohta H, Kinoshita K

Advances and Applications in Bioinformatics and Chemistry 2012, 5:23-59

Published Date: 7 September 2012

A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery

Li P, Liu DH, Miao L, Liu CX, Sun XL, Liu YJ, Zhang N

International Journal of Nanomedicine 2012, 7:925-939

Published Date: 21 February 2012

Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer

Chauhan A, Zubair S, Tufail S, Sherwani A, Sajid M, Raman SC, Azam A, Owais M

International Journal of Nanomedicine 2011, 6:2305-2319

Published Date: 12 October 2011

Clinical use of topical thrombin as a surgical hemostat

Wesley K Lew, Fred A Weaver

Biologics: Targets and Therapy 2008, 2:593-599

Published Date: 1 August 2008

Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)

Andrea Pession, Fraia Melchionda, Claudia Castellini

Biologics: Targets and Therapy 2008, 2:129-141

Published Date: 26 March 2008

Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL

Greg Hodge, Stephen Davis, Michael Rice, Heather Tapp, Ben Saxon, Tamas Revesz

Biologics: Targets and Therapy 2008, 2:143-149

Published Date: 26 March 2008

Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells

Torsten Hans Schroeder, Wolfgang Artur Krueger, Hans-Jürgen Dieterich, Boris Nohé

Biologics: Targets and Therapy 2008, 2:151-160

Published Date: 26 March 2008

The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia

Terry Golombick, Terry Diamond

Biologics: Targets and Therapy 2008, 2:161-163

Published Date: 26 March 2008